Un myxome poly-embolique de l’oreillette gauche

Le myxome cardiaque est une tumeur histologiquement bénigne, souvent découverte fortuitement à l'échocardiographie. Elle reste néanmoins grave par ses complications, notamment emboliques. Nous rapportons le cas d'un myxome de l'oreillette gauche compliqué de syndrome coronarien aigu et de multiples accidents vasculaires cérébraux ischémiques. Le diagnostic  d'accidents emboliques est retenu devant l'association d'une tumeur  intracardiaque emboligène, des AVCI et un SCA en l'absence de lésions  d'athérosclérose et l'absence de thrombus intracardiaque. Le patient a  bénéficié d'une exérèse chirurgicale de la tumeur avec des suites opératoires simples. Nous illustrons à travers cette observation le potentiel embolique du myxome qui rend cette tumeur redoutable et nous insistons sur l'intérêt d'une prise en charge chirurgicale urgente

Hémothorax gauche mode de révélation inhabituel d’une dissection aortique

Les épanchements pleuraux liquidiens sont des  complications méconnus  de la dissection aortique et qui peuvent être source de confusion diagnostique devant un contexte de douleur thoracique aigue.Ils se voient plus souvent dans les dissections qui touchent l’aorte ascendante plus rarement dans les dissections confinées à  l’aorte descendante et sont  souvent d’origine réactionnelle rarement des hémothorax par rupture ou fissuration aortique dans la plèvre.Nous rapportons un cas rare de dissection aortique type B de Stanford découvert par un hémothorax gauche évoluant favorablement sous traitement médical 

2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European respiratory society (ERS)

Guidelines summarize and evaluate available evidence with the aim of assisting health professionals in proposing the best management strategies for an individual patient with a given condition. Guidelines and their recommendations should facilitate decision making of health professionals in their daily practice. However, the final decisions concerning an individual patient must be made by the responsible health professional(s) in consultation with the patient and caregiver as appropriate

Heart failure in Europe: Guideline-directed medical therapy use and decision making in chronic and acute, pre-existing and de novo, heart failure with reduced, mildly reduced, and preserved ejection fraction – the ESC EORP Heart Failure III Registry

Aims We analysed baseline characteristics and guideline-directed medical therapy (GDMT) use and decisions in theEuropean Society of Cardiology (ESC) Heart Failure (HF) III Registry. Methods and results Between1November 2018and31December 2020,10162 patients with acute HF (AHF, 39%, age 70 [62-79],36% women) or outpatient visit for HF (61%, age 66 [58-75], 33% women), with HF with reduced (HFrEF, 57%),mildly reduced (HFmrEF,17%) or preserved (HFpEF, 26%) ejection fraction were enrolled from 220 centres in 41European or ESC-affiliated countries. With AHF, 97% were hospitalized, 2.2% received intravenous treatment in theemergency department, and 0.9% received intravenous treatment in an outpatient clinic. AHF was seen by most bya general cardiologist (51%) and outpatient HF most by a HF specialist (48%). A majority had been hospitalized forHF before, but 26% of AHF and 6.1% of outpatient HF had de novo HF. Baseline use, initiation and discontinuation ofGDMT varied according to AHF versus outpatient HF, de novo versus pre-existing HF, and by ejection fraction. Afterthe AHF event or outpatient HF visit, use of any renin-angiotensin system inhibitor, angiotensin receptor-neprilysininhibitor, beta-blocker, mineralocorticoid receptor antagonist and loop diuretics was 89%, 29%, 92%, 78%, and 85%in HFrEF; 89%, 9.7%, 90%, 64%, and 81% in HFmrEF; and 77%, 3.1%, 80%, 48%, and 80% in HFpEF. ConclusionUse and initiation of GDMT was high in cardiology centres in Europe, compared to previous reports from cohortsand registries including more primary care and general medicine and regions more local or outside of Europe andESC-affiliated countries....................................